ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Interleukin-2 Therapy of Metastatic Renal Cell Carcinoma—Predictors of Response
Seminars in Oncology
◽
10.1053/j.seminoncol.2006.06.004
◽
2006
◽
Vol 33
(5)
◽
pp. 583-587
◽
Cited By ~ 29
Author(s):
D MCDERMOTT
◽
M ATKINS
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Interleukin 2
◽
Predictors Of Response
Download Full-text
Related Documents
Cited By
References
1255: Potential Role of Postoperative Azotemia in Predicting Response to Interleukin-2 (IL-2) Immunotherapy Following Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
The Journal of Urology
◽
10.1016/s0022-5347(18)31469-1
◽
2007
◽
Vol 177
(4S)
◽
pp. 414-414
Author(s):
John S. Lam
◽
Rakhee H. Gael
◽
Tobias Klatte
◽
Fairooz F. Kabbinavar
◽
Arie S. Belldegrun
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Potential Role
◽
Interleukin 2
◽
Cytoreductive Nephrectomy
Download Full-text
Fas Ligand Expression in Metastatic Renal Cell Carcinoma During Interleukin-2 Based Immunotherapy
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-04-1111
◽
2004
◽
Vol 10
(23)
◽
pp. 7911-7916
◽
Cited By ~ 8
Author(s):
Frede Donskov
◽
Hans von der Maase
◽
Niels Marcussen
◽
Stephen Hamilton-Dutoit
◽
Hans Henrik Torp Madsen
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Fas Ligand
◽
Interleukin 2
◽
Ligand Expression
Download Full-text
Recurring cutaneous eruption in a patient with metastatic renal cell carcinoma being treated with high-dose interleukin 2
Journal of the American Academy of Dermatology
◽
10.1067/mjd.2003.204
◽
2003
◽
Vol 48
(4)
◽
pp. 602-604
◽
Cited By ~ 9
Author(s):
Fiona O'Reilly
◽
Elizabeth Feldman
◽
James Yangb
◽
Patrick Hwu
◽
Maria L. Turner
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Interleukin 2
◽
High Dose
◽
Cutaneous Eruption
Download Full-text
A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma
Journal of Immunotherapy
◽
10.1097/cji.0000000000000023
◽
2014
◽
Vol 37
(3)
◽
pp. 180-186
◽
Cited By ~ 8
Author(s):
Paul Monk
◽
Elaine Lam
◽
Amir Mortazavi
◽
Kari Kendra
◽
Gregory B. Lesinski
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase I Study
◽
Interleukin 2
◽
High Dose
Download Full-text
Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells
The Journal of Urology
◽
10.1016/s0022-5347(17)35620-3
◽
1993
◽
Vol 150
(3)
◽
pp. 814-820
◽
Cited By ~ 9
Author(s):
J. Philip Kuebler
◽
Robert P. Whitehead
◽
David L. Ward
◽
George P. Hemstreet
◽
Edward C. Bradley
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Interleukin 2
◽
Lymphokine Activated Killer Cells
◽
Killer Cells
◽
Recombinant Interleukin 2
Download Full-text
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2
ecancermedicalscience
◽
10.3332/ecancer.2016.676
◽
2016
◽
Vol 10
◽
Cited By ~ 2
Author(s):
David M Gill
◽
David D Stenehjem
◽
Kinjal Parikh
◽
Joseph Merriman
◽
Arun Sendilnathan
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Interleukin 2
◽
High Dose
◽
Conditional Survival
Download Full-text
Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2
Cancer Immunology Immunotherapy
◽
10.1007/s002620050336
◽
1997
◽
Vol 43
(5)
◽
pp. 293-298
◽
Cited By ~ 11
Author(s):
Rutger L. van Bezooijen
◽
H. Goey
◽
Gerrit Stoter
◽
J. Hermans
◽
G. J. Fleuren
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Prognostic Markers
◽
Interleukin 2
Download Full-text
Long term follow up of 50 patients with metastatic renal cell carcinoma treated with high dose i.v. interleukin. 2
European Journal of Cancer
◽
10.1016/s0959-8049(99)81866-8
◽
1999
◽
Vol 35
◽
pp. S358
Author(s):
M. Libra
◽
A. Buonadonna
◽
A. Freschi
◽
A. Bearz
◽
M. Berretta
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Interleukin 2
◽
High Dose
◽
Long Term Follow Up
Download Full-text
5- fluorouracil blocks T-cell activity during immunochemotherapy in combination with interferon-alpha and interleukin-2 in metastatic renal cell carcinoma
European Urology Supplements
◽
10.1016/s1569-9056(03)80721-2
◽
2003
◽
Vol 2
(1)
◽
pp. 182
Author(s):
K. Rohrmann
◽
R. Oberneder
◽
H. Pohla
◽
A. Hofstetter
◽
M. Siebels
Keyword(s):
Renal Cell Carcinoma
◽
T Cell
◽
Cell Carcinoma
◽
Interferon Alpha
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Interleukin 2
◽
Cell Activity
Download Full-text
STUDY OF ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND INTERLEUKIN-2 FOR METASTATIC RENAL CELL CARCINOMA
The Japanese Journal of Urology
◽
10.5980/jpnjurol1989.84.822
◽
1993
◽
Vol 84
(5)
◽
pp. 822-830
Author(s):
Kunio Nomura
◽
Tomoaki Fujioka
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Adoptive Immunotherapy
◽
Renal Cell
◽
Interleukin 2
◽
Lak Cells
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close